Who we are
TMSFA is a not for profit organisation that unifies all MS professionals to co-ordinate a strategic approach to change. The TMSFA community is free to join and connects HCPs to provide support and share best practice to address service variation.
Uniting MS professionals to transform care for all
Transforming MS for All was set up following the national service and DMT prescribing audit undertaken in 2020. The results of the audit highlighted recommendations that would benefit from strategic national collaboration of all MS stakeholders, in a community interest company.
For speed and efficiency, TMSFA did not set up as an organisation in its own right but is being hosted by an existing community interest company called Transform MS CIC. This enables all of the income which is generated to be retained for TMSFA activities.
Core Operational Team
A small multi-professional, well-networked group overseeing the routine activities and driving the ambition of TMS4A.
Leadership Team
14 members representing their services, regions and professions across the UK. Playing a key role in communications and decision making.
Regional Ambassadors
10 members who work closely with the leadership team to highlight local issues, promote TMS4A and share best practice examples.
Professions we support
Transforming MS for All is representative of all the professions working with PLwMS and the delivery of those services. Our members drive the content through interactive forums, making it relevant and current to all.
MS Consultant Neurologists
MS Specialist Nurses
Neuropharmacists
Allied Healthcare Professionals
Healthcare Coordinators & Administrators
Researchers
Meet the team
The dedicated professionals driving Transforming MS for All forward.
Joela Mathews
Lead Neuropharmacist
Dr David Rog
Consultant Neurologist
Prof. Jeremy Hobart
Consultant Neurologist
Jerry Clough
Chief Executive
Aimée Milne
Communications Officer
Sponsorship & funding
TMSFA is a not for profit initiative hosted by Transform MS CiC. TMS4A has been awarded grants and sponsorship from different pharmaceutical industry partners. The partners have had no influence or control over the input or output of any of the projects or work to date.
We are working with members of the UK MS professional groups including UKMSNA, ABN MS Advisory group, UKCPA and TIMs.
Get in touch
Contact information
If you would like to learn more about getting involved in the TMSFA Community or you would like to chat with our operational team, please complete the form here and we will be in touch.
info@transformingmsforall.org
Have a question, send us and email and one of the team will respond, usually within 24 hours (within normal working hours).
Send us a message
Jerry Clough
Chief Executive
Jerry is a highly experienced healthcare professional having worked extensively in both the public and private sectors.
Jerry lives on the edge of Dartmoor with his wife and together they are time-limited foster carers looking after children under 5 for typically a little under a year at a time. They have 3 grown up children.
Current Role & Responsibilities
Jerry is the Chief Executive of Transforming MS for All, ensuring that the programme has clear strategic direction, is able to deliver on its plans and people’s expectations of the organisation and that it engages with the wide range of stakeholders and people living with MS that are the reason TMS4All was created.
Background
Jerry had an NHS career of nearly 20 years, with senior positions as Chief Executive, Finance Director and Operations from Cumbria to Yorkshire and finally in Devon.
He worked extensively across the country as an independent consultant supporting health and social care development and as a trained Executive Coach with individuals, organisations and Boards.
Jerry spent seven years with United Health Group first leading the development of population management products and approaches to identify those in greatest need of care then leading the NHS facing business after he had headed up the successful acquisition of EMIS, the leading primary care health records system.
Aimée Milne
Communications Officer
Aimee is our Communications Officer. She holds a BSc in Biochemistry, where her studies focused on medicinal chemistry and drug design. After completing her degree, she began her career as a Metabolism Chemist.
Driven by a passion for making scientific information more accessible, Aimée pursued an MSc in Science Communication. Her studies centred on identifying barriers to science information for hard-to-reach audiences and developing strategies to overcome these obstacles. Specifically, her research project explored how visuals can enhance scientific understanding for adults with ADHD and/or dyslexia.
Aimee says “Growing up with a parent with MS, I truly understands how vital community networks and effective care are as lifelines for all those affected by MS. I am so looking forward to working collaboratively with our growing community to work towards TMSFA’s goals”
Dr David Rog
Consultant Neurologist
David is a Consultant Neurologist with an interest in MS at Salford Royal, where he continues to help assess and follow-up over 2500 disease modifying treatment patients.
David is also Neurosciences Divisional Chief Clinical Information Officer (DCCIO), developing digital enablers to improve care, including in the MS space. He also collaborates with the UK MS Register, Optimise and TONiC research groups.
Prof. Jeremy Hobart
Consultant Neurologist
Dr. Jeremy Hobart is a Consultant Neurologist at Derriford Hospital, and Professor at the Plymouth University Peninsula Schools of Medicine and Dentistry. His clinical sub-specialist interest is the diagnosis and management of people with multiple sclerosis.
Jeremy Hobart’s research interest is rating scales for measuring health outcomes. He has led the development of a number of rating scales, has published widely in this area, and holds over £7 million in research grants.
Joela Mathews
Lead Neuropharmacist
Joela Mathews is the Lead Neuroscience Pharmacist for Barts Health NHS Trust where she has worked nearly 20 years. In recent years she has led a growing team of neuroscience pharmacists to provide medicine optimisation services to the inpatients and also the growing number of day case and out patients seen by the trust.
Joela is an active member of the Royal Pharmaceutical Society (RPS) and recently gained Faculty status.